Your browser doesn't support javascript.
loading
Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers.
Engeseth, Grete May; Stieb, Sonja; Mohamed, Abdallah Sherif Radwan; He, Renjie; Stokkevåg, Camilla Hanquist; Brydøy, Marianne; Fuller, Clifton Dave; Garden, Adam S; Rosenthal, David I; Phan, Jack; Morrison, William H; Reddy, Jay P; Wu, Richard; Zhang, Xiaodong; Frank, Steven Jay; Brandon Gunn, Gary.
Afiliação
  • Engeseth GM; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Norway; Department of Physics and Technology, University of
  • Stieb S; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: SMStieb@mdanderson.org.
  • Mohamed ASR; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: ASMohamed@mdanderson.org.
  • He R; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: RHe1@mdanderson.org.
  • Stokkevåg CH; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway. Electronic address: hanquist.stokkevag@helse-bergen.no.
  • Brydøy M; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: marianne.brydoy@helse-bergen.no.
  • Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: CDFuller@mdanderson.org.
  • Garden AS; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: agarden@mdanderson.org.
  • Rosenthal DI; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: dirosenthal@mdanderson.org.
  • Phan J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jphan@mdanderson.org.
  • Morrison WH; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: whmorrison@mdanderson.org.
  • Reddy JP; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: JReddy@mdanderson.org.
  • Wu R; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: rywu@mdanderson.org.
  • Zhang X; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: xizhang@mdanderson.org.
  • Frank SJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: sjfrank@mdanderson.org.
  • Brandon Gunn G; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: GBGunn@mdanderson.org.
Radiother Oncol ; 151: 119-125, 2020 10.
Article em En | MEDLINE | ID: mdl-32679304
ABSTRACT
BACKGROUND AND

PURPOSE:

To characterize patterns and outcomes of brain MR image changes after proton therapy (PT) for skull base head and neck cancer (HNC). MATERIAL AND

METHODS:

Post-treatment MRIs ≥6 months were reviewed for radiation-associated image changes (RAIC) in 127 patients. All patients had received at least a point dose of 40 Gy(RBE) to the brain. The MRIs were rigidly registered to planning CTs and RAIC lesions were contoured both on T1 weighted (post-contrast) and T2 weighted sequences, and dose-volume parameters extracted. Probability of RAIC was calculated using multistate survival analysis. Univariate/multivariate analyses were performed using Cox Regression. Recursive partitioning analysis was used to investigate dose-volume correlates of RAIC development.

RESULTS:

17.3% developed RAIC. All RAIC events were asymptomatic and occurred in the temporal lobe (14), frontal lobe (6) and cerebellum (2). The median volume of the contrast enhanced RAIC lesion was 0.5 cc at their maximum size. The RAIC resolved or improved in 45.5% of the patients and were stable or progressed in 36.4%. The 3-year actuarial rate of developing RAIC was 14.3%. RAIC was observed in 63% of patients when V67 Gy(RBE) of the brain ≥0.17 cc.

CONCLUSION:

Small RAIC lesions after PT occurred in 17.3% of the patients; the majority in nasopharyngeal or sinonasal cancer. The estimated dose-volume correlations confirm the importance of minimizing focal high doses to brain when achievable.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia com Prótons / Neoplasias de Cabeça e Pescoço Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia com Prótons / Neoplasias de Cabeça e Pescoço Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2020 Tipo de documento: Article